4-[5-(4-Fluorophenyl)-1H-imidazol-4-yl]pyridine
暂无分享,去创建一个
[1] S. Laufer,et al. Targeting the ribose and phosphate binding site of p38 mitogen-activated protein (MAP) kinase: synthesis and biological testing of 2-alkylsulfanyl-, 4(5)-aryl-, 5(4)-heteroaryl-substituted imidazoles. , 2008 .
[2] G. Gattow,et al. Kristallographische Computer-Programme für die CDC-3300. , 1971 .
[3] Maria Cristina Burla,et al. SIR97: a new tool for crystal structure determination and refinement , 1999 .
[4] C. Peifer,et al. New approaches to the treatment of inflammatory disorders small molecule inhibitors of p38 MAP kinase. , 2006, Current topics in medicinal chemistry.
[5] Anthony L. Spek,et al. Structure validation in chemical crystallography , 2009, Acta crystallographica. Section D, Biological crystallography.
[6] E. A. O'neill,et al. Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase. , 1999, Journal of Medicinal Chemistry.
[7] G. Sheldrick. A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.